Follow
Claus Roehrborn
Claus Roehrborn
Verified email at utsouthwestern.edu
Title
Cited by
Cited by
Year
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
JD McConnell, CG Roehrborn, OM Bautista, GL Andriole Jr, CM Dixon, ...
New England Journal of Medicine 349 (25), 2387-2398, 2003
27392003
Radical prostatectomy versus observation for localized prostate cancer
TJ Wilt, MK Brawer, KM Jones, MJ Barry, WJ Aronson, S Fox, JR Gingrich, ...
New England Journal of Medicine 367 (3), 203-213, 2012
21912012
Update on AUA guideline on the management of benign prostatic hyperplasia
KT McVary, CG Roehrborn, AL Avins, MJ Barry, RC Bruskewitz, ...
The Journal of urology 185 (5), 1793-1803, 2011
1536*2011
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
JD McConnell, R Bruskewitz, P Walsh, G Andriole, M Lieber, ...
New England Journal of Medicine 338 (9), 557-563, 1998
15271998
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ...
Journal of clinical oncology: official journal of the American Society of …, 2007
10642007
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study
CG Roehrborn, P Siami, J Barkin, R Damião, K Major-Walker, I Nandy, ...
European urology 57 (1), 123-131, 2010
9862010
Female stress urinary incontinence clinical guidelines panel summary report on surgical management of female stress urinary incontinence
GE Leach, RR Dmochowski, R Appell, JG Blaivas, HR Hadley, KM Luber, ...
The Journal of urology 158 (3), 875-880, 1997
9691997
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
CG Roehrborn, P Boyle, JC Nickel, K Hoefner, G Andriole
Urology 60 (3), 434-441, 2002
8932002
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients
MC Hall, S Womack, AI Sagalowsky, T Carmody, MD Erickstad, ...
Urology 52 (4), 594-601, 1998
8341998
Benign prostatic hyperplasia: an overview
CG Roehrborn
Reviews in urology 7 (Suppl 9), S3, 2005
768*2005
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
AJ Stephenson, SF Shariat, MJ Zelefsky, MW Kattan, EB Butler, BS Teh, ...
Jama 291 (11), 1325-1332, 2004
7552004
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial
SA Kaplan, CG Roehrborn, ES Rovner, M Carlsson, T Bavendam, Z Guan
Jama 296 (19), 2319-2328, 2006
7292006
Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials
P Boyle, AL Gould, CG Roehrborn
Urology 48 (3), 398-405, 1996
6501996
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses
Y Lotan, CG Roehrborn
Urology 61 (1), 109-118, 2003
6072003
A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder
CR Chapple, CG Roehrborn
European urology 49 (4), 651-659, 2006
5722006
The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial
JC Nickel, CG Roehrborn, MP O'Leary, DG Bostwick, MC Somerville, ...
European urology 54 (6), 1379-1384, 2008
5322008
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia
CG Roehrborn, P Boyle, AL Gould, J Waldstreicher
Urology 53 (3), 581-589, 1999
5321999
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia
VJM Verhoeven, PG Hysi, R Wojciechowski, Q Fan, JA Guggenheim, ...
Nature genetics 45 (3), 314-318, 2013
5262013
The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year …
CG Roehrborn, P Siami, J Barkin, R Damião, K Major-Walker, B Morrill, ...
The Journal of urology 179 (2), 616-621, 2008
4942008
Pathology of benign prostatic hyperplasia
CG Roehrborn
International journal of impotence research 20 (3), S11-S18, 2008
4802008
The system can't perform the operation now. Try again later.
Articles 1–20